322 related articles for article (PubMed ID: 12684629)
1. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer.
Machida S; Ohwada M; Fujiwara H; Konno R; Takano M; Kita T; Kikuchi Y; Komiyama S; Mikami M; Suzuki M
Oncology; 2003; 65(2):102-7. PubMed ID: 12931014
[TBL] [Abstract][Full Text] [Related]
3. [Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Nishida M; Satoh Y; Nishide K; Tsunoda H; Kubo T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2209-15. PubMed ID: 10635306
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction.
Kanzawa F; Koizumi F; Koh Y; Nakamura T; Tatsumi Y; Fukumoto H; Saijo N; Yoshioka T; Nishio K
Clin Cancer Res; 2001 Jan; 7(1):202-9. PubMed ID: 11205910
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study.
Yamamoto K; Kokawa K; Umesaki N; Nishimura R; Hasegawa K; Konishi I; Saji F; Nishida M; Noguchi H; Takizawa K
Oncol Rep; 2009 Apr; 21(4):1005-9. PubMed ID: 19288001
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y
Clin Cancer Res; 2009 Jul; 15(13):4348-55. PubMed ID: 19509138
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.
Kudoh S; Takada M; Masuda N; Nakagawa K; Itoh K; Kusunoki Y; Negoro S; Matsui K; Takifuji N; Morino H
Jpn J Cancer Res; 1993 Feb; 84(2):203-7. PubMed ID: 8385085
[TBL] [Abstract][Full Text] [Related]
8. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs.
Hiramatsu HP; Kikuchi Y; Seto H; Nagata I
Anticancer Drugs; 2000 Aug; 11(7):573-8. PubMed ID: 11036961
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
Cao S; Rustum YM
Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.
Tsuda H; Hashiguchi Y; Nishimura S; Miyama M; Nakata S; Kawamura N; Negoro S
Br J Cancer; 2004 Sep; 91(6):1032-7. PubMed ID: 15292935
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
[TBL] [Abstract][Full Text] [Related]
12. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.
Adachi S; Ogasawara T; Wakimoto E; Tsuji Y; Takemura T; Koyama K; Takayasu Y; Inoue J; Nakao N
Cancer; 2001 Jan; 91(1):74-9. PubMed ID: 11148562
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
Abou-Taleb HA; Koshiyama M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Abiko K; Yamanoi K; Murakami R; Horikawa N; Taha AA; Kitamura S; Konishi I
J Int Med Res; 2016 Apr; 44(2):346-56. PubMed ID: 26831404
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
16. [Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
Miki T; Kotake T
Hinyokika Kiyo; 1993 Dec; 39(12):1221-5. PubMed ID: 8285173
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.
Kodama J; Takemoto M; Seki N; Nakamura K; Hongo A; Moriya S; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2008; 18(6):1300-4. PubMed ID: 18284451
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a new anti-cancer drug regimen against uterine cervical cancer in nude mice].
Fushiki H; Hidaka T; Hori S; Fujimura M; Yamakawa Y; Izumi R
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1981-5. PubMed ID: 9350246
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
